<i>In vitro</i> co-culture and <i>in vivo</i> experiments revealed that PLXNC1 could impair the cytotoxicity of CD8<sup>+</sup> T cells, thus facilitating immune evasion by CRC cells. Here, CD8A is linked to colorectal carcinoma.